Gene Therapy Market Research Reports & Industry Analysis

According to our (Global Info Research) latest study, the global Telomere Gene Therapy market size was valued at US$ 22.64 million in 2025 and is forecast to a readjusted size of US$ 239 million by 20...

The global Telomere Gene Therapy market size is expected to reach $ 239 million by 2032, rising at a market growth of 37.1% CAGR during the forecast period (2026-2032). Telomere gene therapy is an ear...

According to our (Global Info Research) latest study, the global Gene Therapy Drug Delivery Tube market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 20...

The global Gene Interference Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gene interference service...

The global miRNA Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. miRNA inhibitor is a specially desi...

The global Small Interfering RNA (siRNA) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Small interfering RNA...

The Global Viral Vector and Plasmid DNA Manufacturing Market is projected to expand from USD 7.17 Billion in 2025 to USD 13.43 Billion by 2031, achieving an 11.03% CAGR. This sector specializes in pro...

The global AAV Vector Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV (Adeno-Associated Virus...

The global GMP Viral Vector Manufacturing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. GMP viral vector man...

The global Viral and Non Viral Vector Manufacturing market size is predicted to grow from US$ 1942 million in 2025 to US$ 4518 million in 2032; it is expected to grow at a CAGR of 13.1% from 2026 to 2...

The global Adeno-Associated Virus Gene Therapy market size is predicted to grow from US$ 1798 million in 2025 to US$ 3008 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032. U...

The global Gene Therapy for Neurodegenerative Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United...

The global AAV Vector CDMO Services market size is predicted to grow from US$ 172 million in 2025 to US$ 681 million in 2032; it is expected to grow at a CAGR of 22.2% from 2026 to 2032. AAV (Adeno-As...

The global Viral Vector CDMO Services market size is predicted to grow from US$ 814 million in 2025 to US$ 3661 million in 2032; it is expected to grow at a CAGR of 24.4% from 2026 to 2032. Viral Vect...

The global AAV Manufacturing Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV (Adeno-Associated Vir...

The global Gene Therapy in Cardiovascular Disorder market size is predicted to grow from US$ 593 million in 2025 to US$ 2317 million in 2032; it is expected to grow at a CAGR of 21.9% from 2026 to 203...

The global RNAi Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. RNAi Therapy is a new treatment method...

The global Gene Vector market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Gene Vector is...

The Japan Gene Therapy Market was valued at US$ 148.06 Million in 2024 and is anticipated to reach US$ 904.94 Million by 2033, at a CAGR of 0.203 from 2026 to 2032. The report delivers in-depth insigh...

According to our (Global Info Research) latest study, the global Cell Gene Overexpression Service market size was valued at US$ 918 million in 2025 and is forecast to a readjusted size of US$ 1236 mil...

The global Cell Gene Overexpression Service market size is expected to reach $ 1236 million by 2032, rising at a market growth of 4.4% CAGR during the forecast period (2026-2032). Cell Gene Overexpres...

The Gene Therapies – Pipeline insights – Size, Share, Industry, Forecast and outlook (2026-2033) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delive...

The global gene therapy market size was valued at USD 6.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 19.3 Billion by 2034, exhibiting a CAGR of 12.27% from 2026-20...

The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, ... are engaged in strategic mergers & facility acquisitions to meet growing requirements of viral vectors within the pharmaceutical and biotech industries and to broaden their ...

The Viral Vector Manufacturing Market was valued at USD 0.9 billion in 2022 and is anticipated to reach USD 3.8 billion by 2031, at a CAGR of 0.203 from 2026 to 2032. The report delivers in-depth insi...

The gene therapy CDMO market size is expected to grow from US$ 2.60 billion in 2025 to US$ 14.17 billion by 2034; it is projected to register a CAGR of 20.3% during 2026-2034. The increasing prevalenc...

The global viral vector market size was estimated at USD 4.25 billion in 2025 and is projected to reach USD 10.22 billion by 2033, growing at a CAGR of 11.69% from 2026 to 2033. The increasing prevale...

According to our (Global Info Research) latest study, the global Custom Adeno-Associated Virus (AAV) Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$...

The Cancer Gene Therapy Market was valued at US$ 3.97Billion in 2024 and is anticipated to reach US$ 19.97Billion by 2033, at a CAGR of 0.198 from 2026 to 2032. The report delivers in-depth insights i...

The cell and gene therapy market size is expected to grow from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031; it is projected to register a CAGR of 25.5% during 2025-2031. The increasing preva...

... this report analyzes the top players in global market, and splits the Hemophilia Gene Therapy market by product type and applications/end ... and hospital visits, and transitioning patients from severe to mild hemophilia. The global Hemophilia Gene Therapy market is valued at xx million USD in 2017 and is ...

... with high investment in research marketing and they will monopoly position in the industry. The global Oncolytic Virus Therapy market is valued at 2 million ... top players in global market, and splits the Oncolytic Virus Therapy market by product type and applications/end industries. Market Segment by Companies, ...

The global Oncolytic Virus Therapy market size is expected to reach $ 236 million by 2032, rising at a market growth of 10.1% CAGR during the forecast period (2026-2032). Oncolytic Virus Therapy is an...

The global Hemophilia Gene Therapy market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Hemophilia is a rare bleeding disorder...

The North America Viral Vector And Plasmid DNA Manufacturing Market was valued at in and is anticipated to reach by 2029, at a CAGR of 0.25 from 2026 to 2032. The report delivers in-depth insights int...

The SMN1 Gene Replacement Market was valued at US$ 1.21 billion in 2023 and is anticipated to reach US$ 1.76 billion by 2031, at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insight...

The Global SCD/?-Thal Gene Therapy Outlook 2025–2033: Size, Trends, Key Players was valued at US$ 83.87 Million in 2024 and is anticipated to reach US$ 380.42 Million by 2033, at a CAGR of 0.184 from...

The Global Gene Transfer Technologies Market was valued at US$ 3.78 Billion in 2024 and is anticipated to reach US$ 8.74 Billion by 2033, at a CAGR of 0.098 from 2026 to 2032. The report delivers in-d...

The Adeno Associated Virus Vectors Manufacturing Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dyna...

The Gene Therapy Market was valued at US$ 4.80 Billion in 2024 and is anticipated to reach US$ 35.91 Billion by 2033, at a CAGR of 0.231 from 2026 to 2032. The report delivers in-depth insights into k...

The Europe Gene Therapy Market was valued at US$ 1,030.70 Million in 2024 and is anticipated to reach US$ 8,780.77 Million by 2033, at a CAGR of 0.249 from 2026 to 2032. The report delivers in-depth i...

The Gene Therapy For Rare Disease Market was valued at US$ 3.01 Billion in 2024 and is anticipated to reach US$ 24.54 Billion by 2033, at a CAGR of 0.265 from 2026 to 2032. The report delivers in-dept...

The Dystrophin Gene Therapy Market was valued at US$ 1.91 billion in 2024 and is anticipated to reach US$ 12.00 billion by 2033, at a CAGR of 0.206 from 2026 to 2032. The report delivers in-depth insi...

The Viral Vector and Plasmid DNA Manufacturing Market was valued at USD 2.85 billion in 2021 and is anticipated to reach by 2031, at a CAGR of 0.142 from 2026 to 2032. The report delivers in-depth ins...

The Asia-Pacific Gene Therapy Market was valued at US$ 1.06 Billion in 2024 and is anticipated to reach US$ 14.59 Billion by 2033, at a CAGR of 0.341 from 2026 to 2032. The report delivers in-depth in...

The US Gene Therapy Market was valued at US$ 2,812.92 million in 2024 and is anticipated to reach US$ 21,701.51 million by 2033, at a CAGR of 0.235 from 2026 to 2032. The report delivers in-depth insi...

Cell and gene therapies in rare disorders represent a groundbreaking approach to treating genetic diseases that have traditionally lacked effective treatments. These therapies work by modifying a pati...